Not signed up yet? Be one of the first to receive our new reports and publications by signing up to our mailing list. Email [email protected]

This month sees the next NICE/NICE DSU/ABPI Masterclass Programme for 2023 - Methods for the analysis of non-randomised, patient level data for the estimation of treatment effects To find out more about it and how to register, visit: shorturl.at/ansN5

DSU publication: Does EQ-5D tell the whole story? shorturl.at/ePQU8 Project: An investigation into methods for demonstrating when a generic, preference-based measure of health-related quality of life misrepresents health gain- shorturl.at/acs29

DSU TSD series - The TSDs provide a review of the current state of the art in each topic area, and make clear recommendations on the implementation of methods and reporting standards where it is appropriate to do so. sheffield.ac.uk/nice-dsu/tsds

This month sees the first NICE/NICE DSU/ABPI masterclass for 2024 - What makes a good submission? To find out more about it and how to register, visit: shorturl.at/stwKY

“Severity Weights” were introduced to NICE Methods in January 2022. TSD23 provides guidance on how severity shortfalls can be calculated, including the data sources that can be used in most appraisals. Find it here: shorturl.at/PQVX4

We've reorganised our technical support documents. The TSDs provide a review of the current state of the art in each topic area, and make clear recommendations on the implementation of methods and reporting standards where it is appropriate to do so. sheffield.ac.uk/nice-dsu/tsds

Treatment switching in randomised controlled trials: Trial design, what to adjust for, how, and reporting guidelines. The DSU’s new TSD 24 provides an update to TSD 16 – out now! shorturl.at/uJKMO

Registration for the next masterclass on 30th Sept is now open - Methods for the analysis of non-randomised, patient level data for the estimation of treatment effects :bit.ly/3W6ioJG NICE/NICE DSU/ABPI

TSD 22, 23 and 24 one page summaries now available. Download these and previous TSD one page summaries here: bit.ly/3Sx5ljz For the full range of TSDs, please visit: bit.ly/3WutPLi

NICE replaced the cost effectiveness modifier for “End-of-Life” with one for “Severity” in 2022 but there are concerns that severity is not being used as often as expected. Our report investigates this issue, using info from more than 500 TA decisions bit.ly/3zsQ3WI

Registration for the next online masterclass on the 4th & 5th Nov is now open - Methods for mapping health utilities for NICE submissions:-bit.ly/3Nvy05I NICE/NICE DSU/ABPI

NEW TSD 25 evidence synthesis one page summary. To view visit: bit.ly/3ZxIreu To view the series of TSDs in the area of evidence synthesis, visit: bit.ly/3ZsV8XX For all available TSD one page summaries, visit: bit.ly/3Sx5ljz

The newly released TSD26 Expert Elicitation for assessing long-term survival outcomes is now available on the DSU website. Complete details and a dossier template can be accessed here: bit.ly/42QmMjp

Registration now open for the next NICE DSU masterclass - Optimising NICE submissions in oncology. This is an in-person event being held by the ABPI on 12 June. NICE NICE DSU ABPI More details: bit.ly/4iEVWjU Future masterclases: bit.ly/3Ym8IwK

Check out our one page summary for the latest TSD: TSD 26: Expert elicitation for long-term survival outcomes on the TSd one page summary page, here: sheffield.ac.uk/nice-dsu/tsds/…

NEW TSD: Prioritising Studies and Outcomes for NICE HealthTech Literature Reviews. Reviews of clinical effectiveness can vary widely in the volume/type of available evidence. This TSD outlines approaches to further narrow or widen inclusion: buff.ly/YMKqpHb

Check out our one page summary for the latest TSD: TSD 27: Prioritising Studies and Outcomes for NICE HealthTech Literature Reviews. This TSD outlines approaches to further narrow or widen inclusion: buff.ly/YMKqpHb